Abstract
This study looks at secondary care utilisation metrics as an effectiveness indicator of Clozapine initiation in 89 patients over the following year compared to the year prior to initiation. It was found that there was an overall reduction of outpatient use and crisis activity, with a marginal drop in bed usage. Medical outpatient use increased, as did physical health monitoring. Overall, compared with costs over the year preceding Clozapine initiation, an estimated saving per patient of £1800 was estimated over the first year post initiation, increasing to £3100 per patient if those with premorbid dissocial and substance misuse traits were excluded, raising the issue of better treatment targeting.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
N/A - No funding required for this study
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declaration of Interests – None
Data availability statement – Data template provided as part of submission
Author contribution – Dr Prasanna N. de Silva is the sole author, responsible for study design, data collection, presentation of findings and drafting manuscript.
Data Availability
Data availability statement – Data template / bank provided as part of submission
